Farther Finance Advisors LLC Buys 735 Shares of GE HealthCare Technologies Inc. $GEHC

Farther Finance Advisors LLC grew its stake in shares of GE HealthCare Technologies Inc. (NASDAQ:GEHC) by 16.4% during the second quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The fund owned 5,228 shares of the company’s stock after buying an additional 735 shares during the period. Farther Finance Advisors LLC’s holdings in GE HealthCare Technologies were worth $387,000 as of its most recent filing with the Securities and Exchange Commission.

A number of other hedge funds and other institutional investors have also recently added to or reduced their stakes in GEHC. JPMorgan Chase & Co. boosted its holdings in GE HealthCare Technologies by 49.9% during the first quarter. JPMorgan Chase & Co. now owns 5,140,549 shares of the company’s stock worth $414,894,000 after buying an additional 1,711,963 shares during the last quarter. Nuveen LLC bought a new position in GE HealthCare Technologies during the first quarter worth about $77,058,000. GAMMA Investing LLC boosted its holdings in GE HealthCare Technologies by 9,524.6% during the first quarter. GAMMA Investing LLC now owns 771,507 shares of the company’s stock worth $62,268,000 after buying an additional 763,491 shares during the last quarter. Eminence Capital LP boosted its holdings in GE HealthCare Technologies by 38.7% during the first quarter. Eminence Capital LP now owns 1,819,129 shares of the company’s stock worth $146,822,000 after buying an additional 507,101 shares during the last quarter. Finally, Homestead Advisers Corp boosted its holdings in GE HealthCare Technologies by 92.7% during the first quarter. Homestead Advisers Corp now owns 988,600 shares of the company’s stock worth $79,790,000 after buying an additional 475,500 shares during the last quarter. Institutional investors own 82.06% of the company’s stock.

Analyst Upgrades and Downgrades

GEHC has been the topic of several recent analyst reports. Citigroup lifted their price objective on GE HealthCare Technologies from $89.00 to $93.00 and gave the company a “buy” rating in a report on Thursday, July 31st. Morgan Stanley set a $74.00 price objective on GE HealthCare Technologies in a report on Thursday, September 18th. BTIG Research reiterated a “buy” rating on shares of GE HealthCare Technologies in a report on Monday, July 14th. Zacks Research upgraded GE HealthCare Technologies from a “hold” rating to a “strong-buy” rating in a report on Thursday, August 28th. Finally, Wall Street Zen cut GE HealthCare Technologies from a “buy” rating to a “hold” rating in a report on Saturday, September 20th. One analyst has rated the stock with a Strong Buy rating, eight have issued a Buy rating and two have assigned a Hold rating to the company’s stock. Based on data from MarketBeat.com, the company presently has a consensus rating of “Moderate Buy” and an average price target of $88.40.

GE HealthCare Technologies Trading Up 1.3%

NASDAQ GEHC opened at $72.46 on Monday. The stock has a market capitalization of $33.08 billion, a price-to-earnings ratio of 14.85, a PEG ratio of 2.77 and a beta of 1.13. The stock’s 50 day moving average price is $74.35 and its two-hundred day moving average price is $72.71. The company has a debt-to-equity ratio of 0.85, a quick ratio of 0.93 and a current ratio of 1.16. GE HealthCare Technologies Inc. has a 52 week low of $57.65 and a 52 week high of $94.80.

GE HealthCare Technologies (NASDAQ:GEHC) last released its earnings results on Wednesday, July 30th. The company reported $1.06 EPS for the quarter, beating the consensus estimate of $0.91 by $0.15. The firm had revenue of $5 billion for the quarter, compared to analysts’ expectations of $4.96 billion. GE HealthCare Technologies had a return on equity of 23.93% and a net margin of 11.22%.The business’s quarterly revenue was up 3.5% compared to the same quarter last year. During the same quarter in the previous year, the business posted $1.00 EPS. GE HealthCare Technologies has set its FY 2025 guidance at 4.430-4.630 EPS. As a group, analysts anticipate that GE HealthCare Technologies Inc. will post 4.68 earnings per share for the current fiscal year.

GE HealthCare Technologies Dividend Announcement

The company also recently announced a quarterly dividend, which will be paid on Friday, November 14th. Shareholders of record on Friday, October 24th will be paid a $0.035 dividend. The ex-dividend date is Friday, October 24th. This represents a $0.14 annualized dividend and a yield of 0.2%. GE HealthCare Technologies’s payout ratio is presently 2.87%.

GE HealthCare Technologies Company Profile

GE HealthCare Technologies Inc engages in the development, manufacture, and marketing of products, services, and complementary digital solutions used in the diagnosis, treatment, and monitoring of patients in the United States, Canada, and internationally. The company operates through four segments: Imaging, Ultrasound, Patient Care Solutions, and Pharmaceutical Diagnostics.